Asymmetric synthesis of sulfoximines, sulfonimidoyl fluorides, and sulfonimidamides enabled by an enantiopure bifunctional S(VI) reagent

19 April 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

An increased interest to expand the three-dimensional chemical space for the design of new materials and medicines has created a demand for isosteric replacement groups of commonly used molecular functionality. The structural and chemical properties of chiral S(VI) functional groups provide unique spatial and electronic features compared to their achiral sulfur- and carbon-based counterparts. Manipulation of the S(VI) center to introduce structural variation with stereochemical control has remained a synthetic challenge. The stability of sulfonimidoyl fluorides and the efficiency of sulfur fluorine exchange (SuFEx) chemistry has enabled the development of an enantiopure bifunctional S(VI) transfer reagent (t-BuSF) to overcome current synthetic limitations. Here, this reagent platform serves as a chiral SuFEx template for the rapid asymmetric synthesis of over seventy different sulfoximines, sulfonimidoyl fluorides and sulfonimidamides with excellent enantiopurity and good overall yields. Furthermore, the practical utility of t-BuSF was demonstrated in the syntheses of enantiopure pharmaceutical intermediates and analogs.

Keywords

SuFEx
sulfur(VI)
sulfoximine
sulfonimidamide
sulfonimidoyl fluoride

Supplementary materials

Title
Description
Actions
Title
Supplmentary Information
Description
Experimental procedures, graphical reagent preparation, compound characterization, chiral HPLC, NMR
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.